Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2012 | 1 |
2013 | 3 |
2014 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.
Crit Rev Immunol. 2014;34(5):399-432. doi: 10.1615/critrevimmunol.2014011577.
Crit Rev Immunol. 2014.
PMID: 25404047
Free PMC article.
Review.
Immunotoxin targeting CD133(+) breast carcinoma cells.
Ohlfest JR, Zellmer DM, Panyam J, Swaminathan SK, Oh S, Waldron NN, Toma S, Vallera DA.
Ohlfest JR, et al. Among authors: waldron nn.
Drug Deliv Transl Res. 2013 Apr;3(2):195-204. doi: 10.1007/s13346-012-0066-2.
Drug Deliv Transl Res. 2013.
PMID: 25787984
Item in Clipboard
A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma.
Waldron NN, Barsky SH, Dougherty PR, Vallera DA.
Waldron NN, et al.
Target Oncol. 2014 Sep;9(3):239-49. doi: 10.1007/s11523-013-0290-9. Epub 2013 Jul 31.
Target Oncol. 2014.
PMID: 23900680
Free PMC article.
Item in Clipboard
Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.
Skubitz AP, Taras EP, Boylan KL, Waldron NN, Oh S, Panoskaltsis-Mortari A, Vallera DA.
Skubitz AP, et al. Among authors: waldron nn.
Gynecol Oncol. 2013 Sep;130(3):579-87. doi: 10.1016/j.ygyno.2013.05.027. Epub 2013 May 27.
Gynecol Oncol. 2013.
PMID: 23721800
Free PMC article.
Item in Clipboard
CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy.
Moertel CL, Xia J, LaRue R, Waldron NN, Andersen BM, Prins RM, Okada H, Donson AM, Foreman NK, Hunt MA, Pennell CA, Olin MR.
Moertel CL, et al. Among authors: waldron nn.
J Immunother Cancer. 2014 Dec 16;2(1):46. doi: 10.1186/s40425-014-0046-9. eCollection 2014.
J Immunother Cancer. 2014.
PMID: 25598973
Free PMC article.
Item in Clipboard
Bispecific targeting of EGFR and uPAR in a mouse model of head and neck squamous cell carcinoma.
Waldron NN, Oh S, Vallera DA.
Waldron NN, et al.
Oral Oncol. 2012 Dec;48(12):1202-7. doi: 10.1016/j.oraloncology.2012.06.002. Epub 2012 Jul 20.
Oral Oncol. 2012.
PMID: 22818892
Free PMC article.
Item in Clipboard
Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer.
Waldron NN, Kaufman DS, Oh S, Inde Z, Hexum MK, Ohlfest JR, Vallera DA.
Waldron NN, et al.
Mol Cancer Ther. 2011 Oct;10(10):1829-38. doi: 10.1158/1535-7163.MCT-11-0206. Epub 2011 Aug 23.
Mol Cancer Ther. 2011.
PMID: 21862685
Free PMC article.
Item in Clipboard
Cite
Cite